News
Researchers have discovered that nicotinamide riboside, a form of vitamin B3, may boost energy in nerve cells and help prevent them being lost in Parkinson's.
Further analysis of the results from a recent clinical trial of the type 2 diabetes drug exenatide in people with Parkinson's has revealed encouraging signs of a positive effect on mood.
To mark World Parkinson's Day on 11 April, we teamed up with the European Parkinson's Disease Association and other organisations around the world to #UniteForParkinsons, a global campaign that aimed to show what Parkinson's truly is.
The trial will test whether drug treatment with a commonly prescribed dementia drug can improve balance and walking and help to prevent falls in people with Parkinson's.
New research shows that scrapping prescription charges for Parkinson's and inflammatory bowel disease could save the NHS money.
Key information about the recent recall of neurology patients in Northern Ireland.
We are pleased to announce that a Parkinson's research project has been awarded the inaugural BenevolentAI Award. The project will use an artificial intelligence platform’s capabilities to reason, deduce and suggest entirely new treatments for Parkinson’s.
Parkinson's UK has released new figures on the number of people with the condition. What do they mean for bringing forward the day no one fears Parkinson's?
Celebrities, Trustees and people with Parkinson's attended a St James's Palace reception on Tuesday to celebrate Jane Asher’s anniversary as our President.
An international team has developed a cutting-edge technique, enabling human brain tissue to be studied in 3D.